Corbion has received vital regulatory approvals from China’s General Administration of Customs (GACC) to introduce its algae-derived omega-3 DHA products in the country’s growing human and animal nutrition markets. This development positions Corbion to meet the rising demand for sustainable nutrition solutions in China.
The company secured registrations for its omega-3 products under the AlgaPrime™ DHA and AlgaVia™ DHA brands. Both offerings are designed to cater to the increasing need for high-quality nutrition in both animals and people. With all necessary regulatory steps now completed, Corbion is set to launch its algae-based solutions across China.
“China is an important and fast-growing market for algae-derived omega-3 solutions in both food and feed,” said Tim Rutten, Vice President Nutrition & Pharma at Corbion. “With these registrations and licenses in place, we can now offer Chinese customers and partners our proven ingredients that align with their focus on quality, safety, and sustainability.”
Corbion’s AlgaVia™ DHA and AlgaPrime™ DHA provide a clean, concentrated source of omega-3 DHA. Produced from microalgae using controlled fermentation with sugar cane and renewable energy, these products lessen the reliance on marine resources while minimising carbon emissions.
Trusted by brands across human nutrition, aquaculture, livestock, and petfood sectors, these omega-3 solutions enhance nutritional profiles and bolster supply chain resilience amid rising global demand. Corbion emphasises its commitment to quality, reliability, and adaptability by offering flexible omega-3 products in various formats, tailored to meet diverse customer needs.
